4 recruiting, 3 not yet recruiting, 1 active not recruiting, 1 completed. 2 Phase 1, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 2 |
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Peanut Allergies: new trials by email Literature Review of Peanut Allergies trials Research Report on Peanut Allergies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Flow CAST® Peanut Trial Basophil activation test - Peanut Allergies | Not yet recruiting | Bühlmann Laboratories AG | 245 | 2026-10-01 | 2026-08-20 | |
| Efficacy, Safety and Pharmacokinetics of LP-003 in Peanut Allergic Patients LP-003 Injection, Placebo Injection - Peanut Allergies | Phase 2 | Not yet recruiting | Longbio Pharma (Suzhou) Co., Ltd. | 80 | 2026-09-01 | 2026-08-25 |
| Multi-Food Oral Immunotherapy for Peanut and Tree Nuts Multi-Food Oral Immunotherapy (Multi-OIT) with Peanut and Tree Nuts Proteins, Standard of Care (Elimination Diet) - Food Allergies, Food Allergy in Children | Not applicable | Not yet recruiting | Medical University of Warsaw | 39 | 2026-09-01 | 2026-08-13 |
| Single Ascending and Multiple Ascending Dose Study of LCA-0061 LCA-0061, Placebo - Atopic Disease, Peanut Allergies | Phase 1 | Recruiting | Lycia Therapeutics, Inc. | 72 | 2026-06-26 | 2026-07-14 |
| BÜHLMANN BAT (Basophil Activation Test) in Allergy Diagnosis (Exploratory Pilot Study) Allergy Testing, Peanut Allergies | Completed | Bühlmann Laboratories AG | 38 | 2026-05-15 | 2026-07-17 | |
| A Long Term, Observational Follow-Up Study of Children and Young People Who Underwent an 18-Month Course of Oral Immunotherapy Treatment for Peanut, Egg or Milk Allergy (5-15 Years Post-Treatment) Food Allergies, Peanut Allergies | Recruiting | Murdoch Childrens Research Institute | 147 | 2026-01-13 | 2026-02-02 | |
| Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy MY006 Low Dose, MY006 Mid Dose, MY006 High Dose - Peanut Allergies | Phase 1 | Recruiting | Mabylon AG | 48 | 2025-12-06 | 2026-10-20 |
| The Role of Filaggrin Mutations and Sensitization Pathways in Allergic Rhinitis and Peanut Allergy Allergic Rhinitis, Peanut Allergies | Active not recruiting | Dr. Anne Ellis | 100 | 2016-03-01 | 2024-06-27 | |
| Blood Samples for the Study of Peanut, Tree Nut and Other Food Allergies Peanut Allergies, Tree Nut Allergies | Recruiting | University of Colorado, Denver | 270 | 2014-02-01 | 2022-12-19 |
Peanut Hypersensitivity (9) · Food Hypersensitivity (3) · Nut Hypersensitivity (2) · Dust Mite Allergy (1) · Egg Hypersensitivity (1) · Hypersensitivity (1) · Milk Hypersensitivity (1) · Rhinitis, Allergic (1) · Venom Hypersensitivity (1)
Hypersensitivity, Immediate (9) · Immune System Diseases (9) · Nut and Peanut Hypersensitivity (9) · Hypersensitivity (8) · Food Hypersensitivity (6) · Nose Diseases (2) · Otorhinolaryngologic Diseases (2) · Respiratory Hypersensitivity (2) · Respiratory Tract Diseases (2) · Rhinitis (2) · Rhinitis, Allergic (1) · Rhinitis, Allergic, Perennial (1)
Basophil Degranulation Test (1) · Elimination Diets (1) · Standard of Care (1)
Bühlmann Laboratories AG (2) · Dr. Anne Ellis (1) · Longbio Pharma (Suzhou) Co., Ltd. (1) · Lycia Therapeutics, Inc. (1) · Mabylon AG (1) · Medical University of Warsaw (1) · Murdoch Childrens Research Institute (1) · University of Colorado, Denver (1)
Canada (2) · United States (2) · Australia (1) · Germany (1) · Poland (1)
Adriana Chebar Lozinsky Rolnik (1) · Anne K Ellis, MD (1) · Nadia Tchao, MD (1) · Stephen Dreskin, MD, PhD (1)
PMID 31437325, PMID 33217410, PMID 35150723, PMID 35386644
UL1TR001082 (1)